¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"central and lateral intermediate substance"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • cement substance
    Á¢ÇÕÁú, ½Ã¸àÆ®¹°Áú
  • chromophil substance
    È£»ö¼Òü, »ö¼Òģȭ¹°Áú
  • depressor substance
    °¨¾Ð¹°Áú
  • ferromagnetic substance
    °­ÀÚ¼º¹°Áú
  • gelatinous substance
    Á©¶óƾ¹°Áú
  • gray substance
    ȸ»öÁú, ȸ¹éÁú
  • ground substance
    ¹ÙÅÁÁú, ±âÀú¹°Áú, ±âÁú
  • horny substance
    °¢Áú
  • intercellular cement substance
    ¼¼Æ÷»çÀÌÁ¢ÇÕÁú, ¼¼Æ÷°£Á¢ÇÕÁú
  • intercellular substance
    ¼¼Æ÷»çÀ̹°Áú, ¼¼Æ÷°£¹°Áú
  • metachromatic substance
    ÀÌ¿°»ö¹°Áú, ÀÌ¿°¼º¹°Áú(ì¶æøàõÚªòõ)
  • Nissl substance
    ´Ï½½¹°Áú
  • odoriferous substance
    Çâ·á
  • posterior perforated substance
    µÚ°üÅëÁú, ÈİüÅëÁú
  • pressor substance
    Ç÷¾Ð»ó½Â¹°Áú
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • positive and negative syndrome
    ¾ç¼ºÀ½¼ºÁõÈıº
  • suck and snout reflex
    ÀԴٽñâ¹Ý»ç, »¡°íÇÓ±â¹Ý»ç
  • sip and puff switch
    È£Èí½ºÀ§Ä¡
  • to and fro absorbent system
    ¿Õº¹Èí¼ö½Äȸ·Î
  • to-and-fro sound
    ¸¶ÂûÀ½
  • amyotrophic lateral sclerosis
    ±ÙÀ°À§Ãà°¡ÂʰæÈ­Áõ
  • lateral sacral artery
    °¡ÂʾûÄ¡µ¿¸Æ
  • lateral gastrocnemius bursa
    °¡ÂÊÀåµýÁö±ÙÁÖ¸Ó´Ï
  • lateral maxillary buttress
    °¡ÂÊÀ§ÅλÀ¹öÆÀº®
  • lateral canthus
    °¡ÂÊ´«±¸¼®
  • lateral chain
    (¢¡side chain) °ç»ç½½
  • lateral nasal cartilage
    °¡ÂÊÄÚ¿¬°ñ
  • lateral decubitus
    ¿·´©¿ò, Ãø¿ÍÀ§, ¿·´©¿îÀÚ¼¼
  • lateral cerebral fossa
    ´ë³ú°¡ÂÊ¿À¸ñ
  • lateral corporal fold
    ¸öÅë°¡ÂÊÁÖ¸§
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • posterior lateral nasal arteries
    °¡ÂʵÚÄÚµ¿¸Æ
  • primary lateral sclerosis
    ¿ø¹ß(¼º) Ãø»è°æÈ­(Áõ)(¡­ö°ßãÌãûùñø).
  • primary lateral sclerosis
    ¿ø¹ß(¼º) Ãø»è°æÈ­(Áõ)(ê«Û¡(àõ) ö°ßãÌãûùñø)
  • prominence of lateral semicircular canal
    °¡ÂÊ¹Ý°í¸®°üÀ¶±â
  • prominence of lateral semicircular canal ³ª prominentia canalis semicircularis lateralis
    ¿ÜÃø¹Ý°í¸®°ñ°üÀ¶±â, ¿ÜÃø¹Ý±Ô°üÀ¶±â(èâö°ÚâЮηëØÑÃ).
  • prominence of lateral semicircular canal ³ª prominentia canalis semicircularis lateralis
    ¿ÜÃø¹Ý°í¸®°ñ°üÀ¶±â, ¿ÜÃø¹Ý±Ô°üÀ¶±â(èâö°ÚâЮηëØÑÃ).
  • pterygoid muscle lateral
    ¿ÜÃø³¯°³±Ù, ¿ÜÀ͵¹±Ù(èâìÏÔÍÐÉ).
  • DSM-I=Diagnostic and Statistical Manual of Mental Disorders-I
    Á¤½ÅÀå¾Ö(º´)Áø´ÜÅë°èÆí¶÷ Á¦ 1ÆÇ
  • Death and dying
    »ç¸Á°úÀÓÁ¾
  • ENT =ear, nose and throat
    À̺ñÀÎÈİú(ÇÐ)
  • General anesthesia, reticular activating system and.
    Àü½Å¸¶Ãë(îïãóئö­), ¸Á»óüȰ¼ºÈ­°è(ØÑßÒô÷üÀàõûùͧ)
  • Gravity, cardiac output and
    Áß·Â(ñìÕô), ½É¹ÚÃâ·®(ãýÚÑõóÕá)
  • KUB= kidney, ureter and bladder
    ½Å-´¢°ü-¹æ±¤ ´Ü¼øÃÔ¿µ
  • Kell antigen and antibody
    ÄÌÇ׿øÇ×ü
  • PACS (picture archiving and communicating system)
    ÆÑ½º, ¿µ»ó ÀúÀå ¹× Àü¼Û ü°è
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • intermediate hybrid
    Áß°£ÀâÁ¾(¡­íÚðú).
  • intermediate hypothalamic region
    ½Ã»óÇϺÎÁß°£±¸¿ª
  • intermediate inheritance
    Áß°£À¯Àü.
  • intermediate interneurone
    Áß°£ºÎÁß°£(ñéÊà)´º¿ì·Ð.
  • intermediate lacunar node
    (Áß°£Ç÷°üÄ­¸²ÇÁÀý)
  • intermediate laryngeal cavity
    Áß°£Èĵΰø°£
  • intermediate layer
    Áß°£Ãþ
  • intermediate layer
    Áß°£Ãþ(ñéÊàöµ).
  • intermediate layer
    Áß°£ÆÇ
  • intermediate layer spinous layer
    Áß°£Ãþ °¡½ÃÃþ
  • intermediate line
    Áß°£´É¼±
  • intermediate line ³ª linea intermedia
    Áß°£¼±(ñéÊààÊ).
  • intermediate lobe
    Áß°£¿±, ÁßÇϼö(ñéù»á÷)¿±.
  • intermediate lumbar lymph nodes
    Áß°£Ç㸮¸²ÇÁÀý
  • intermediate lymph nodes
    Áß°£¸²ÇÁÀý
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • Acrosomal substance
    ÷´Üü¹°Áú
    [¿¾ ¿ë¾î] ÷´Üü¹°Áú
  • Acrosomal substance
    ÷´Üü¹°Áú
    [¿¾ ¿ë¾î] ÷´ÜüÁú
  • Subacrosomal substance
    ÷´Üü¹Ø¹°Áú
    [¿¾ ¿ë¾î] ÷´ÜüÇϹ°Áú
  • Subacrosomal substance
    ÷´Üü¹Ø¹°Áú
    [¿¾ ¿ë¾î] ÷´ÜüÇÏÁú
  • Substance of synaptic cleft
    Æ´»õ¹°Áú
    [¿¾ ¿ë¾î] ¿­³»Áú
  • Osteoid substance
    Dz»À¹°Áú
    [¿¾ ¿ë¾î] °ñ¾çÁú
  • (Intermediate lacunar node)
    (Áß°£Ç÷°üÄ­¸²ÇÁÀý)
    [¿¾ ¿ë¾î] Áß°£¿ä¿ÍÀÓÆÄÀý
  • Gigantocellular intermediate reticular nucleus
    °Å´ë¼¼Æ÷Áß°£±×¹°ÇÙ
    [¿¾ ¿ë¾î] °Å´ë¼¼Æ÷Áß°£¸Á»óüÇÙ
  • Posterior intermediate sulcus
    µÚÁß°£°í¶û
    [¿¾ ¿ë¾î] ÈÄÁß°£±¸
  • Medullary intermediate reticular nucleus
    ¼û³úÁß°£±×¹°ÇÙ
    [¿¾ ¿ë¾î] ¿¬¼öÁß°£¸Á»óüÇÙ
  • Intermediate hypothalamic region
    ½Ã»óÇϺÎÁß°£±¸¿ª
    [¿¾ ¿ë¾î] ½Ã»óÇϺÎÁß°£ºÎ
  • Inferior pontine intermediate reticular nuleus
    ¾Æ·¡´Ù¸®³úÁß°£±×¹°ÇÙ
    [¿¾ ¿ë¾î] Çϱ³³úÁß°£¸Á»óüÇÙ
  • Superior pontine intermediate reticular nucleus
    À§´Ù¸®³úÁß°£±×¹°ÇÙ
    [¿¾ ¿ë¾î] »ó±³³úÁß°£¸Á»óüÇÙ
  • Intermediate
    Áß°£
    [¿¾ ¿ë¾î] Áß°£
  • Intermediate branch
    Áß°£°¡Áö
    [¿¾ ¿ë¾î] Áß°£Áö
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • lateral meniscus
    ¿ÜÃø¹Ý¿ù
  • lateral nucleus
    Ãø»èÇÙ
  • lateral pharyngeal wall
    ÀεÎÃøº®
  • lateral pterygoid lamina
    Àͻ󵹱â¿ÜÃøÆÇ
  • lateral pterygoid muscle
    ¿ÜÃøÀ͵¹±Ù
  • lateral recess syndrome
    ¿ÜÃøÇÔ¿äÁõÈıº
  • lateral rectus muscle
    ¿ÜÁ÷±Ù
  • lateral resolution
    Ãø¹æÇâ ÇØ»ó·Â
  • lateral sacrococcygeal ligament
    ¿Ü̵̿¹ÌÀδë
  • lateral semicircular canal
    ¿ÜÃø°ñ¹Ý±Ô°ü, ¿ÜÃø¹Ý±Ô°ü
  • lateral shadow
    ¿ÜÃø±×¸²ÀÚ
  • lateral thoracic artery
    ¿ÜÃøÈ䵿¸Æ
  • lateral tubercle
    ¿ÜÃø°áÀý
  • lateral ventricle
    Ãø³ú½Ç
  • lateral wall echo
    Ãøº®¿¡ÄÚ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
CTT cefotetan; central tegmental tract; central transmission time; compressed tablet triturate; computer...
CVO central vein occlusion; central venous oxygen; Chief Veterinary Officer; credentialing verification ...
ASSERT improving Alcohol and Substance abuse Services and Educating providings to Refer patients to Treatme...
ABC absolute basophil count; absolute bone conduction; acalculous biliary colic; acid balance control; a...
ICF immunodeficiency-centromeric instability-facial anomalies [syndrome]; indirect centrifugal flotation...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
IT Intermediate trophoblast
IF Intermediate-sized filaments
MI Metabolic Intermediate
MIP Mitochondrial intermediate peptidase
ROI Reactive oxygen intermediate
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • white substance
    ¹é»ö Áú
  • acute and late normal tissue effects£¨Á¤»ó Á¶Á÷ ±Þ¼º ¿µÇ⣩

    acute angle

    ¿¹°¢
    Á÷°¢º¸´Ù ÀÛÀº °¢.
  • American Society of Therapeutic Radiology and Oncology
    ¹Ì±¹ ¹æ»ç¼±Á¾¾çÇÐȸ
  • atmospheric temperature and pressure
    ´ë±â Ç¥ÁØ »óÅÂ
  • atrophoderma of Pasini and Pierini
    ÆÄ½Ã´Ï ÇÇ¿¡¸®´Ï ÇǺΠÀ§ÃàÁõ
  • bone and joint surgery
    °ñ°üÀý ¿Ü°ú
  • bread and butter pericarditis
    »§-¹öÅÍ ¸ð¾ç ½É¸·¿°
  • Center for Device and Radiological Health
    ?
  • cheek and tongue retractor
    Çù¼³ °ßÀαâ
  • child abuse and neglect
    ¾Æµ¿ Çдë¿Í ¹æÄ¡
  • communication codes and characteristics
    È­ÀÇ ºÎÈ£¿Í ¼ºÁú
  • congenital and developmental bone disorder
    ¼±Ãµ¼º ¹× ¹ßÀ°¼º °ñ Àå¾Ö
  • congenital and developmental muscle disorder
    ¼±Ãµ¼º ¹× ¹ßÀ°¼º ±ÙÀå¾Ö
    Ãâ»ý ½ÃºÎÅÍ ±ÙÀúÇϸ¦ ³ªÅ¸³»°í Èå´ÃÈå´ÃÇÑ ¾ÆÀÌ. flo
  • connective tissue sheath of Key and Retzius
    Ű-·¹Ä¡¿ì½ºÀÇ °áÇÕ Á¶Á÷ ÃÊ
    ½Å°æ³»¸·, ƯÈ÷ ½Å°æ¼¶À¯ Á¾¸»Áö ÁÖÀ§ÀÇ ¾ãÀº ¿¬Àå.
  • crown and loop space maintainer
    Å©¶ó¿î¿£µå ·çÇÁÇü °£°Ý À¯Áö ÀåÄ¡
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
spongy substance Bone in which the spicules or trabeculae form a three-dimensional latticework (cancellus) with the interstices filled with embryonal connective tissue or bone marrow.
Synonym: substantia trabecularis, cancellous bone, spongy bone, spongy substance, trabecular bone.
(05 Mar 2000)
standard substance A pure, authentic substance used for identification purposes.
(05 Mar 2000)
Stilling's gelatinous substance The central gray matter of the spinal cord surrounding the central canal.
Synonym: substantia intermedia centralis et lateralis, anterior gray column, Stilling's gelatinous substance, substantia gelatinosa centralis.
(05 Mar 2000)
neurosecretory substance The secretion of nerve cell bodies located in the hypothalamus; the substance is transported by way of hypothalamo-hypophysial tract fibres into the neurohypophysis where the terminals of the nerve fibres contain the secretion. As seen in the fibres and terminals with a light microscope, the substance appears as Herring bodies or hyaline bodies of the pituitary (see under body).
See: hyaline bodies of pituitary.
(05 Mar 2000)
Nissl substance The material consisting of granular endoplasmic reticulum and ribosomes that occurs in nerve cell bodies and dendrites.
Synonym: basophil substance, basophilic substance, chromophil substance, Nissl bodies, Nissl granules, substantia basophilia, tigroid bodies, tigroid substance.
(05 Mar 2000)
substance The material constituting an organ or body, also called substantia.
Origin: L. Substantia
(18 Nov 1997)
substance abuse Maladaptive pattern of drug or alcohol use that may lead to social, occupational, psychological, or physical problems.
(05 Mar 2000)
substance abuse detection Detection of drugs that have been abused, overused, or misused, including legal and illegal drugs. Urine screening is the usual method of detection.
(12 Dec 1998)
substance abuse disorders A class of mental disorders in which behavioural and biological changes are associated with regular use of alcohol, drugs, and related substances that affect the central nervous system and personal and social functioning.
(05 Mar 2000)
substance abuse, intravenous Abuse, overuse, or misuse of a substance by its injection into a vein.
(12 Dec 1998)
substance abuse treatment centres Health facilities providing therapy and/or rehabilitation for substance-dependent individuals. Methadone distribution centres are included.
(12 Dec 1998)
substance dependence A pattern of behavioural, physiologic, and cognitive symptoms that develop due to substance use or abuse; usually indicated by tolerance to the effects of the substance and withdrawal symptoms that develop when use of the substance is terminated.
(05 Mar 2000)
substance-induced organic mental disorders Mental disorders caused by use of drugs, e.g., cocaine.
(05 Mar 2000)
substance of lens of eye That which constitutes the lens of the eye, composed of a nucleus and a cortex and covered by an epithelium.
Synonym: substantia lentis.
(05 Mar 2000)
substance P A vasoactive intestinal peptide (1348 D) found in the brain, spinal ganglia and intestine of vertebrates. Induces vasodilatation, salivation and increases capillary permeability. Sequence: RPKPQFFGLM.
(18 Nov 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • by and by
    ÀÌÀ¹°í
  • by-and-by
    ¹Ì·¡
  • checks and balances
    °ßÁ¦¿Í ±ÕÇü
  • every now and then
    À̵û±Ý
  • here and there
    ¿©±âÀú±â¿¡
  • hide-and-go-seek
    ¼û¹Ù²ÀÁú
  • hide-and-seek
    ¼û¹Ù²ÀÁú
  • hole-and-corner
    ºñ¹ÐÀÇ
  • kith and kin
    ģôÁö±â, Àϰ¡Ä£Ã´
  • now and again
    À̵û±Ý
  • now and then
    ¶§¶§·Î (every ... ... ....)
  • off and on
    ºÒ±ÔÄ¢ÇϰÔ
  • on and on
    °è¼ÓÇÏ¿©
  • once and for all
    ¸¶Áö¸·À¸·Î
  • one and all
    ÇÑ »ç¶÷ ºüÁü¾øÀÌ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á